Addex Therapeutics Ltd

NASDAQ: ADXN · Real-Time Price · USD
8.00
0.48 (6.38%)
At close: Aug 15, 2025, 3:47 PM
7.94
-0.75%
After-hours: Aug 15, 2025, 04:00 PM EDT

Addex Therapeutics Ltd Cash Flow Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
7.06M -10.56M -20.8M -15.35M
Depreciation & Amortization
260.12K 305.95K 323.14K 347.61K
Stock-Based Compensation
n/a 1.79M 3.68M 1.18M
Other Working Capital
-1.36M -92.76K 409.77K -665.15K
Other Non-Cash Items
-11.46M 249.64K 204.13K 32.93K
Deferred Income Tax
n/a n/a n/a -150.59K
Change in Working Capital
-1.23M 213.76K 157.68K -761.57K
Operating Cash Flow
-5.37M -7.99M -16.44M -14.71M
Capital Expenditures
-1.27K -6.84K -581 -31.55K
Cash Acquisitions
-473.27K n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a 3.55K 1.24K
Other Investing Acitivies
5.12M n/a 3.55K 1.24K
Investing Cash Flow
4.65M -6.84K 2.97K -30.31K
Debt Repayment
-73.69K -281.79K -288.08K -309.62K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-62.29K 3.2M 1.71M 2.75M
Financial Cash Flow
104.92K 5.26M 3.1M 16.4M
Net Cash Flow
-523.74K -3.09M -13.53M 1.79M
Free Cash Flow
-5.37M -8M -16.44M -14.74M